The Silent Signals: How Biomarkers Predict Future Heart Events
Cardiac biomarkers are not just for diagnosing a heart attack in the moment; they are also powerful predictors of future cardiac events. In many cases, elevated levels of certain biomarkers, even in the absence of a heart attack, can signal an underlying risk. For example, high-sensitivity C-reactive protein (hs-CRP) is a general marker of inflammation in the body, and chronic inflammation is a known risk factor for heart disease. Similarly, elevated levels of B-type natriuretic peptide (BNP) in patients with heart failure can indicate a higher risk of future hospitalization or death. By monitoring these "silent signals," doctors can stratify a patient's risk and implement preventive measures, such as lifestyle changes or medication, long before a catastrophic event occurs. This shift from reactive to proactive care is a testament to the prognostic value of these biomarkers and the expanding scope of the Cardiac Biomarkers Market.